• HeartSciences won FDA 510(k) clearance (K260005) for its MyoVista wavECG device as a 12-lead resting electrocardiograph.
• Clearance covers ECG acquisition and interpretation for adult, pediatric patients in hospitals, healthcare facilities.
• Authorization excludes the AI-ECG algorithm; HeartSciences has no timeline to commercialize the device.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060830PRIMZONEFULLFEED9840283) on October 06, 2026, and is solely responsible for the information contained therein.